Patents by Inventor Olga Valota

Olga Valota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8940334
    Abstract: The present invention relates to pharmaceutical composition containing nemorubicin hydrochloride incorporated in microspheres. The compositions are useful for chemoembolization, particularly for loco regional treatment of tumors.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: January 27, 2015
    Assignee: Nerviano Medical Sciences S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Alessandro Martini, Paolo Elia Cappella
  • Publication number: 20120121716
    Abstract: The present invention relates to pharmaceutical composition containing nemorubicin hydrochloride incorporated in microspheres. The compositions are useful for chemoembolisation, particularly for loco regional treatment of tumors.
    Type: Application
    Filed: April 30, 2008
    Publication date: May 17, 2012
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Alessandro Martini, Paolo Elia Cappella
  • Publication number: 20110021517
    Abstract: The present invention provides a combination of a morpholinyl anthracycline derivative, in particular a methoxy morpholino doxorubicin derivative, or a pharmaceutically acceptable salt thereof, and a demethylating agent, having an antineo-plastic effect. Also provided is the use of the said combinations in the treatment or prevention of metastasis, in the treatment of tumors, as well for reversing the resistance in cells resistant to such a methoxy morpholino doxorubicin derivative.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 27, 2011
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Massimo Broggini
  • Publication number: 20100190736
    Abstract: The present invention provides the combined use of a morpholinyl anthracycline derivative of formula (I) as defined in the specification or a pharmaceutically acceptable salt thereof, such as nemorubicin hydrochloride, and a protein kinase (PK) inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
    Type: Application
    Filed: July 23, 2008
    Publication date: July 29, 2010
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Maria Cristina Geroni, Olga Valota, Dario Ballinari, Aurelio Marsiglio
  • Publication number: 20060264388
    Abstract: The present invention relates to a treatment schedule of nemorubicin administered via the intrahepatic artery in a dosage ranging from about 100 mcg/m2 to about 800 mcg/m2 every 6 weeks to patients with a liver cancer.
    Type: Application
    Filed: February 11, 2004
    Publication date: November 23, 2006
    Inventors: Olga Valota, Maria Facciarini